View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
TUESDAY, May 15 (HealthDay News) -- For patients with acute sinusitis, inhaled corticosteroids provide a small benefit over placebo but only after several weeks, according to a study published in the May/June issue of the Annals of Family Medicine.
Gail Hayward, M.B.B.Chir., D.Phil., from Oxford University in the United Kingdom, and colleagues conducted a systematic review and meta-analysis of studies to investigate the effect of intranasal corticosteroids on the symptoms of acute sinusitis. Six studies, including 2,495 patients with suspected acute sinusitis or rhinosinusitis, who were treated with intranasal corticosteroids or placebo, were included. Antibiotics were also prescribed in five of the studies.
The researchers found that intranasal corticosteroids were associated with a small but significant increase in symptom resolution or improvement at days 14 to 21 (risk difference, 0.08), with the most consistently significant benefits seen for facial pain and congestion. There was a significant beneficial effect noted at 21 days, but not at 14 to 15 days, in subgroup analysis by time of reported outcomes. A significant dose-response relationship was seen on analysis of trials using different doses of mometasone furoate.
"Most patients want to get better in a few days, not three weeks," John Hickner, M.D., M.Sc., from the Cleveland Clinic, writes in an accompanying editorial. "Nasal steroids are not the answer for most patients."
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top